Abstract

Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2021 - Volume 25, Number 5

Page(s): 412

Download in electronic PDF format for $75
  • Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension Page 1

Abstract

A formulation for preparing Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • atropine sulfate
  • formulation
  • oral suspension
  • anticholinergic agent
  • antispasmodic agent
  • muscle spasms
  • belladonna alkaloid
  • d-hyoscyamine
  • l-hyoscyamine

Related Categories

  • FORMULATIONS
  • MUSCULOSKELETAL DISORDERS
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2021
Pg. 412
Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
May/Jun 2017
Pg. 255-263
Stability of Alprazolam, Atropine Sulfate, Glutamine, Levofloxacin, Metoprolol Tartrate, Nitrofurantoin, Ondansetron Hydrochloride, Oxandrolone, Pregabaline, and Riboflavin in SyrSpend SF pH4 Oral Suspensions
Author(s): de Oliveira Ferreira Anderson, Polonini Hudson C, Loures da Silva Sharlene, Cerqueira de Melo Victor Augusto, de Andrade Laura, Fernandes Brandão Marcos Antônio
May/Jun 2003
Pg. 220
Hyoscyamine Sulfate 0.125-mg and Phenobarbital 15-mg/mL Oral Drops
Author(s): Allen Loyd V Jr
Jul/Aug 1997
Pg. 271-273
Atropine Overdosage with a Suppository Formulation Containing Atropine Sulfate
Author(s): Allen Loyd V Jr
Mar/Apr 2022
Pg. 140
Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
May/Jun 2015
Pg. 242
Atropine Sulfate 1% Ophthalmic Solution
Author(s): Allen Loyd V Jr
Nov/Dec 2017
Pg. 491
Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 503
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2003
Pg. 300
Meperidine HCl 100-mg/mL and Atropine Sulfate 0.4-mg/mL Injection
Author(s): Allen Loyd V Jr
Sep/Oct 2005
Pg. 394
Morphine Sulfate 16-mg and Atropine Sulfate 0.4-mg/mL Injection
Author(s): Allen Loyd V Jr
Nov/Dec 2008
Pg. 550-552
Physical Compatibility and Chemical Stability of a Concentrated Solution of Atropine Sulfate (2 mg/mL) for Use as an Antidote in Nerve Agent Casualties
Author(s): Donnelly Ronald F, Corman Celine
Nov/Dec 2018
Pg. 494
Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2020
Pg. 60
Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2020
Pg. 327-336
Stability of Extemporaneous Oral Tramadol, Fluoxetine, and Doxycycline Suspensions in SyrSpend SF pH4
Author(s): Espana B, Joseph-Tornabène F, Jaquet Cécile, Perrot S, Prouillac C
Nov/Dec 2018
Pg. 492
Clonazepam 0.2 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2018
Pg. 493
Diltiazem Hydrochloride 12 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2020
Pg. 136
Quinidine Sulfate 10 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr